Bestatin as a treatment modality in experimental periodontitis

M Kaminska, M Benedyk‐Machaczka… - Journal of …, 2023 - Wiley Online Library
Background Chronic periodontitis (CP), the most prevalent dysbiotic bacteria‐driven chronic
inflammatory disease, is an underestimated global health problem in itself, and due to a …
被引用次数：1 相关文章

[引用][C] Bestatin as a treatment modality in experimental periodontitis

M Kaminska, M Benedyk-Machaczka, K Adamowicz… - 2023 - ruj.uj.edu.pl

Bestatin as a treatment modality in experimental periodontitis.

M Kaminska, M Benedyk-Machaczka… - Journal of …, 2023 - europepmc.org
Background Chronic periodontitis (CP), the most prevalent dysbiotic bacteria-driven chronic
inflammatory disease, is an underestimated global health problem in itself, and due to a …

Bestatin as a treatment modality in experimental periodontitis

M Kaminska, M Benedyk-Machaczka… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Chronic periodontitis (CP), the most prevalent dysbiotic bacteria-driven chronic
inflammatory disease, is an underestimated global health problem in itself, and due to a …

[引用][C] Bestatin as a treatment modality in experimental periodontitis

M Kaminska, M Benedyk-Machaczka… - Journal of …, 2023 - ruj.uj.edu.pl
Bestatin as a treatment modality in experimental periodontitis Przejdź do treści Pomoc A A A
Zmień kontrast Zaloguj English polski   Repozytorium Uniwersytetu Jagiellońskiego …